INTRODUCTION
Microencapsulation is a well known method for the preparation of controlled or extended release dosage forms. Different coating materials and processes are used for microencapsulation of drugs. The literature reviews showed the different criteria for the designing of microparticles according to polymer properties (Bayomi 2004; Sajeev et al., 2002) . Cellulose acetate (CA) is a water insoluble cellulosic polymer and commonly used for the formulations of microparticles, pellets and beads for the delivery of prolonged and sustained therapy (Soppimath et al., 2001) . In the present work cellulose acetate (CA) is chosen as suitable polymer for encapsulating the nimesulide by solvent evaporation technique. Nimesulide (NIM) is described chemically as N-(4-nitro-2-phenoxyphenyl)methane sulfonamide. It is a unique nonsteroidal anti-inflammatory (NSAID) agent having specific affinity to inhibit cyclooxygenase-2 enzyme (Rabasseda 1992) . It is highly effective in reducing pain associated with osteoarthritis, rheumatoid, and other degenerative joints disorders, low back pain, dysmenorrhoea, gynaecological condition, thrombophlebitis, dental pain and inflammations etc. (Bernareggi, 1993; Kulkarni, 2002) . This drug is also associated with some severe side effects due to higher doses such as epigastric pain, heartburn, nausea, diarrhoea, vomiting, peptic ulcer and hepatic impairments. Nimesulide attain peak serum concentrations of 1.98 to 9.85 mg/L within 1.22 to 3.17 hours when given orally and extensively bound to plasma proteins (99%) having half-life 1.56 to 4.95 hr which requires frequent dosing to maintain plasma concentration (Boelsterli, 2002; Peruccae, 1993; Singla et al., 2000) . The objective of this study is to develop sustained release formulation with lower dose of drug to maintain plasma concentration that may increase patients compliance, improved therapeutic efficacy and reduced severity of upper GI side effects because of alteration in delivery pattern via slow release of drug from microparticles.
MATERIAL AND METHODS

Material
Nimesulide B.P. received as gift sample from Nicholas Piramal India Ltd, Pithampur M.P.), cellulose acetate from Zeim Lab. Nagpur. The chemicals such as acetone, methanol, liquid paraffin (heavy and light) and nhexane, were of analytical grade supplied by Merck Chem. Ltd.
Preparation of microparticles
NIM microparticles were prepared by using cellulose acetate polymer as a retardant material and any interaction to the drug was studied by IR spectra.
The microparticles of nimesulide were prepared by modified emulsion solvent evaporation method with modifications (Olive, Rey, 1993; Chowdhary, Ramesh, 1995; Saravanan et al., 2003; Saraf et al., 2006; Dashora et al., 2006a) using polymeric solution (CA) with the different polymer: drug ratio (1:9, 1:6 and 1:3) in 10 mL acetone. This solution was dispersed in a thin stream to previously heated liquid paraffin (1:1 light and heavy, 600 mL at 60±3 °C) in a 1000 mL beaker with stirring rate at 500-1500 rpm. A Remi medium duty stirrer was used for stirring and continued for 15 -30 minutes to disperse the added mixture as fine droplet emulsion. The solvent was removed by evaporation at room temperature (30 ±1 °C) under vacuum (0.80 torr) for 1.0 hour to produce almost spherical microparticles (projection microscope, Quasmo, India). The microparticles were collected by decantation and washed with n-hexane to remove adhering liquid paraffin. The product was then dried to obtained discreet microparticles. Microparticles were prepared using different polymer: drug ratios 1:9,1:6 and 1:3 (NIM-1, NIM-2 and NIM-3), while keeping the other two variables constant i.e. stirring speed 1000 rpm and stirring time 20 min. Similarly, microparticles were also prepared at different stirring rate viz. 500, 1000 and 1500 rpm, keeping the polymer: drug ratio 1:6 and stirring time 20 min. In the same way microparticles were prepared using different stirring time i.e. 15, 20 and 30 min, keeping the polymer: drug ratio 1:6 and stirring speed 1000 rpm.
Characterization of microparticles
Infrared spectra of NIM and NIM loaded microparticles were determined in the range of 4700 to 400 cm -1 using a Fourier-transform infrared spectrophotometer (FT-IR) (model FTIR-8400 S Shimadzu, Japan) from KBr pellets.
The surface morphology of microparticles was performed by a scanning electron microscopy (SEM, LEO 430, London). Microparticles were mounted on stubs and coated for 120 s with a layer of gold using a sputter coater. The size of microparticles was determined by an optical microscopy using a calibrated ocular micrometer (Erma, Japan).
Stability studies were conducted to find out stable product under storage. The microparticles were stored in amber colored glass bottles at elevated temperature i.e., 4±1 °C freezing temperature (FT), 25±1 °C room temperature (RT) and 50±1 °C hot temperature (HT) for a period of 30 days and observed for change in drug content and morphology, i.e. shape and structural integrity, by microscopic and scanning electron microscopy.
Drug content
After stipulated time of storage, an accurate weighed quantity of microparticles (200 mg) was taken and finely powdered. The powdered amount equivalent to 50 mg of NIM was extracted in 10 mL methanol and 20 mL of Effect of processing variables and in-vitro study of microparticulate system of nimesulide 557 pH 6.8 buffer. The insoluble polymer was separate out through the Whatman (0.45 µm) filter paper. The supernatant was assayed spectrophotometrically (UV-1700 -Shimadzu Japan) after suitable dilution at 397nm by using modified method of Dashora et al. (2006b) 
Entrapment efficiency of microparticles
An accurately weighed quantity of microparticles (equivalent to 50 mg NIM) was extracted in 10 mL methanol and 20 mL of pH 6.8-phosphate buffer for 24 h. Coating polymeric material is separated out through the Whatman (0.45 µm) filter paper. The polymer was washed three times (7 mL each time) with buffer and all filtrates were added and assayed spectrophotometrically (UV-1700-Shimadzu Japan) after suitable dilution at 397 nm. The concentration of drug in filtrate was determined from the calibration curve of NIM in alkaline phosphate buffer pH 6.8 and encapsulation efficiency for microparticles was calculated by using equation ( Flow properties of the microparticles were evaluated by determining the angle of repose by fixed funnel and free standing cone method and the compressibility index by tapped density method.
Drug release studies
The USP method II or paddle dissolution test (Model No. USP TDT -06P, Electrolab), was used with a pH 6.8 phosphate buffer as the release medium. The stirring speed was 100 rpm and the temperature of the release medium was kept at 37±0.5 °C. An accurately weighed amount of microparticles equivalent to 100 mg of NIM was added to 900 mL of dissolution medium and methanol was included in the dissolution medium to provide a sink condition, in order to kept the drug below the 10% of the saturation value (Dashora et al., 2006c) . At programmed intervals, 5 mL samples were withdrawn and filter through 0.45 µm Whatman filter and assayed spectrophotometrically at 397 nm using modified method after suitable dilution (Dashora et al., 2006b ). An equivalent quantity of dissolution medium was added at all the withdrawal of sample. The mean of six determinations was used to calculate the drug release from each of the formulation.
Release kinetics
In the present study, two different mathematical equations (Martin, 1983 ) were employed to model the dissolution profile from the NIM microparticles system i.e., (1) first order equation; (2) Higuchi's square root of time equation.
(1) First order model can be expressed as
Where M t is the amount of drug released at time t, M ∞ is the maximal amount of drug released at infinite time, k 1 and k H are the rate constants for first order and Higuchi model, respectively.
RESULTS AND DISCUSSION
In order to study the interaction between NIM and polymer (CA), IR studies were performed using KBr pellet press method. The IR spectra of the NIM indicated the presence of bands at about 900-640 cm (N-H). IR spectra of NIM loaded microparticles of CA also showed the peaks at the same bands. This indicated that there is no interaction between NIM and polymers employed in the microparticles.
The effect of various processing variables of microparticles like polymer concentration, agitation speed and stirring time were studied on particle size, drug entrapment efficiency and drug release study. When polymer concentration was increased from 1:9 to 1:3 (polymer: drug) ratio then particle size increases from 68.8±1.45 to 87.33±1.06 µm. The average diameter of the microparticles at various agitation speeds i.e., 500, 1000 and 1500 rpm were found in decreasing order, i.e., 71.1±1.63 to 69.1±1.05 µm (Table I ). This suggests that the size of the droplets formed during microcapsulation is closely related to the size of final microcapsules, which increased by decreasing the stirring speed. A faster stirring speed 1500 rpm gave much smaller but cohered particles. At lower speed (500 rpm), the mean particle diameter and size distribution of the microparticles increased considerably. The irregularity in shape of microparticles occurred at higher speed (1500 rpm) but discreet and uniform size of microparticles were obtained at 1000 rpm. The average diameter of the microparticles decreases from 78.4±2.05 to 68.23± 0.87 µm on increasing stirring times from 15 to 30 min. The short time (15 min) resulted in aggregates and less discreet microparticles where at high stirring time (30 min) resulted smaller microparticles with increased size distribution. The discreet and uniform size of the microparticles was found at 20 min stirring time.
The maximum entrapment efficiency (75.66±1.86%) was found for NIM-2 formulation. This may be due to that at this polymer: drug ratio, uniform size of drug globules coated with polymer during emulsification process [observed under projection microscope (Quasmo, India)]. The agitation speed affects drug entrapment efficiency of microparticles and it were found to be 73.66±3.15, 77.63±1.81 and 72.71±3.40 with 500-1500 rpm respectively. The lower entrapment efficiency at 500 rpm agitation speed may be due to inadequately stirring of droplets, which leads to increased chances of coalescence. At higher agitation speed i.e., 1500 rpm, it was visually observed that most of the globules were forced towards the wall of the flask due to high rotation and it lowers the contact time between polymer and drug molecules. But at 1000 rpm, no sticking of polymeric material around the walls of flask was visually observed which may leads to improved drug: polymer contact time resulting highest drug entrapment efficiency. The effect of varying stirring time (15-30 min) was also observed for drug entrapment efficiency and found 70.66±1.83 and 73.46±1.95% at lower and higher stirring time. The maximum entrapment efficiency (77.83±0.50%) was observed at stirring time 20 min because of sufficient time for tightening of polymeric network around the globules unlike in case of lower and higher stirring time (Table I ). The data of entrapment efficiency indicates that approx 23% of the drug appears to leach out to the external phase (liquid paraffin) during the process and it is confirmed by estimation of residual drug content in external phase. So, microparticles which prepared under optimized conditions i.e., polymer: drug ratio 1:6, agitation speed 1000 rpm and stirring time 20 min were found to be spherical in shape, uniform in size and exhibited a smooth surface. The uniform size and smooth surface of microparticles was due to the tightening of the polymeric net work leading to shrinkage of the microcapsules as the time of evaporation of solvent increased. The optimum size of microcapsules were obtained with 20 min stirring time because larger time 30 min gave smaller microparticles and shorter time 15 min gave aggregated and less discreet microparticles. The surface morphology of microparticles prepared under optimized conditions was shown in Figure 5 .
Data of average diameter and entrapment efficiency of all CA microparticles were compared (SSPS soft ware) to each other statistically using unpaired t-test and one-way analysis of variance (ANOVA) at a significant level P ≤ 0.05.
The flowability of microparticles was determined in terms of angle of repose and compressibility index (Table  III) for its application in fabrication of sustained products. Data of average diameter and entrapment efficiency of CA microcapsules were compared statistically using unpaired t-test and one-way analysis of variance (ANOVA) at a significant level P ≤ 0.05
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The angle of repose was found in the range of 23.5±0.4 to 34.4 ± 0.6º and compressibility indices in the range 13.8±0.7 to 23.6±0.6% % suggesting good flowability of particles (Banker, Anderson, 1986) .
The release studies of all microparticles (NIM-1 to NIM-3) were carried out by dissolution data in phosphate buffer pH 6.8. It is calculated as cumulative percent drug release and compared with conventional tablet (Figure 1) . The cumulative percentage drug release in the formulation NIM-1, NIM-2, NIM-3 and conventional tablet (Con. tab.) was found to be 96.29±1.35, 94.21±1.21, 86.23±1.13 and 93.29±0.52 respectively. The drug release from conventional tablet was exhausted within 4 h while microparticles sustained the drug more than 14 h. The study showed that cumulative percentage drug release is influenced by the microparticle size in all formulation and increase in release with decrease in microparticles size. This may be due to the presence of more drug molecules close to their surface in smaller particles for dissolution in the surrounding medium as compared to larger microparticles. In-vitro drug release data showed that 65.36± 2.16 -72.41± 1.89, 54.36± 2.34 -64.29± 1.48% nimesulide were released from NIM-1 and NIM-2 formulations respectively within 4-6 h while only 42.56± 1.68 -54.89± 2.14 nimesulide was released from NIM-3 formulation. To observe the kinetic of drug release, the logarithm of percent drug retained in microparticles versus time was plotted and found straight line (Figure 2) . It indicates that all microparticles follows first order release rate kinetic pattern (Table II) . The first order regression equation and coefficient was shown in Table II . The Table II ) indicating diffusion controlled release from the polymer (Figure 3).
The value of Higuchi's regression coefficient (r) of NIM-2 formulation was found to be more linear (0.9910) than NIM-1 and NIM-3 formulation (Table II) , and also maximum entrapment efficiency were obtained as compared to NIM-1 and NIM-3 microparticles (Table II) . In vitro release data of NIM-2 microparticles were compared with available SR tablets as marketed reference in order to check the feasibility of prepared formulation for the further development of suitable and convenient multiple unit dosage forms with appropriate loading and maintenance dose. The in vitro data showed that NIM-2 microparticles have slower release (K 1 = 0.225% h ). So NIM-2 microparticulate formulation may be utilized for the more extended period of drug release as a maintenance dose.
In order to make stable sustained product, the stability studies showed that microparticles are stable at 4±1°C (RT), 25±1°C (RT) and 50±1°C (HT). The percentage residual drug content of the NIM-1, NIM-2 and NIM-3 microparticles were shown in Table IV at 4±1°C to 50±1°C after 7, 15 and 30 days of storage (Figure 4) . No significant differences in percent residual drug content were observed at ambient and accelerated storage conditions in the prepared formulation indicating all formulations were stable under the stability studies.
CONCLUSION
The study concluded that the processing variables; polymer: drug ratio, agitation speed and stirring time affects the preparation of sustained release nimesulide microparticles by an emulsion solvent evaporation process. 
